Rosiglitazone plus metformin to prevent type 2 diabetes mellitus
- PMID: 20971354
- DOI: 10.1016/S0140-6736(10)61947-2
Rosiglitazone plus metformin to prevent type 2 diabetes mellitus
Comment on
-
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.Lancet. 2010 Jul 10;376(9735):103-11. doi: 10.1016/S0140-6736(10)60746-5. Epub 2010 Jun 3. Lancet. 2010. PMID: 20605202 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical